Jacob E. Till
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
-
- Cancer Genomics and Diagnostics 13
- Oncology 10
- Pancreatic and Hepatic Oncology Research 6
- Cancer Cells and Metastasis 3
- Co-authors
- Erica L. Carpenter (20 shared papers)Sandra Ryeom (3 shared papers)Neha Bhagwat (3 shared papers)Stephanie S. Yee (10 shared papers)Dong Ha Bhang (1 shared paper)Peter A. Galie (1 shared paper)Keri Schadler (1 shared paper)Christopher S. Chen (1 shared paper)
- Journals
- Clinical Cancer Research (4 papers)Neuro-Oncology (4 papers)Journal of Clinical Oncology (3 papers)Oncotarget (2 papers)Neuro-Oncology Advances (2 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Jacob E. Till
27 papers receiving 658 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 217
- Genetics 102
- Oncology 142
- Rehabilitation 33
- Molecular Biology 306
Countries citing papers authored by Jacob E. Till
This map shows the geographic impact of Jacob E. Till's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob E. Till with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob E. Till more than expected).
Fields of papers citing papers by Jacob E. Till
This network shows the impact of papers produced by Jacob E. Till. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob E. Till. The network helps show where Jacob E. Till may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacob E. Till, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 134 | |
| 2 | 2019 | 110 | |
| 3 | 2020 | 92 | |
| 4 | 2019 | 85 | |
| 5 | 2017 | 38 | |
| 6 | 1986 | 31 | |
| 7 | 2020 | 24 | |
| 8 | 2012 | 23 | |
| 9 | 2022 | 22 | |
| 10 | 2021 | 22 | |
| 11 | 2012 | 19 | |
| 12 | 2024 | 13 | |
| 13 | 2023 | 11 | |
| 14 | 2009 | 11 | |
| 15 | 2021 | 9 | |
| 16 | 2022 | 7 | |
| 17 | 2021 | 3 | |
| 18 | 2025 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2022 | 1 |
About Jacob E. Till
Jacob E. Till is a scholar working on Cancer Research, Oncology, Molecular Biology, Genetics and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 664 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (13 papers), Pancreatic and Hepatic Oncology Research (6 papers), Glioma Diagnosis and Treatment (6 papers), Cancer Cells and Metastasis (3 papers), Respiratory Support and Mechanisms (2 papers), Cancer-related gene regulation (2 papers), Immune cells in cancer (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Cancer Research (217 citations), Genetics (102 citations), Oncology (142 citations), Rehabilitation (33 citations) and Molecular Biology (306 citations). Jacob E. Till has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Erica L. Carpenter, Sandra Ryeom, Neha Bhagwat, Stephanie S. Yee, Dong Ha Bhang, Peter A. Galie, Keri Schadler, Christopher S. Chen, Nicholas J. Thomas and Kathleen M. Sturgeon. Their work appears in journals such as Clinical Cancer Research, Neuro-Oncology, Journal of Clinical Oncology, Oncotarget and Neuro-Oncology Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.